 LONDON--BUSINESS WIRE--Aimmune Therapeutics UK Ltd., a Nestlé Health Science company developing and commercialising pharmaceutical therapies to prevent, manage, and treat food and metabolic related diseases, today announced it will present new treatment satisfaction data for its oral immunotherapy drug, PALFORZIA, at the European Academy of Allergy and Clinical Immunology EAACI Hybrid Congress 2021 in Poland. The company will share updated treatment satisfaction data evaluated in its Phase 